Contributors

Chris Anderson  Department of Dermatology, Linköping University, Linköping, Sweden

Jorge Arrese  Department of Dermatopathology, University Hospital of Liège, Liège, Belgium

Heather A. E. Benson  School of Pharmacy, Curtin University of Technology, Perth, Western Australia, Australia

James Birchall  Welsh School of Pharmacy, Cardiff University, Cardiff, U.K.

Michael Bonner  School of Pharmacy, University of Bradford, Bradford, West Yorkshire, U.K.

Marcel Borgers  Barrier Therapeutics NV, Geel, Belgium, and Department of Molecular Cell Biology, Maastricht University, Maastricht, Netherlands

Joke Bouwstra  Leiden/Amsterdam Center for Drug Research, Leiden, the Netherlands

Keith R. Brain  An-eX Analytical Services Ltd. and Cardiff University, Cardiff, U.K.

Robert L. Bronaugh  Office of Cosmetics and Colors, Food and Drug Administration,

College Park, Maryland, U.S.A.

Daniel A. W. Bucks  Dow Pharmaceutical Sciences, Inc., Petaluma and Department of Dermatology, School of Medicine, University of California, San Francisco,

San Francisco, California, U.S.A.

Christine F. Carson  Department of Microbiology and Immunology, School of Biomedical, Biomolecular, and Chemical Sciences, Faculty of Life and Physical Sciences, The University of Western Australia, Crawley, Western Australia, Australia

Geert Cauwenbergh  Barrier Therapeutics Inc., Princeton, New Jersey, U.S.A.

Thomas C. K. Chan  ArQule Inc., Woburn, Massachusetts, U.S.A.

Susan Ciotti  Pfizer Global Research and Development, Ann Arbor, Michigan, U.S.A. Robert A. Coburn  Therex LLC, Buffalo, New York, U.S.A.

Sheree E. Cross  Therapeutics Research Unit, School of Medicine, University of Queensland, Princess Alexandra Hospital, Woolloongabba, Queensland, Australia

Grazyna Cynkowska  Psivida Inc., Watertown, Massachusetts, U.S.A. Tadeusz Cynkowski  Psivida Inc., Watertown, Massachusetts, U.S.A.

Maxim Darvin  Universitätsklinikum Charité, Klinik für Dermatologie, Venerologie und Allergologie, Berlin, Germany

Liévin Daugimont  Unité de Pharmacie Galénique, Université Catholique de Louvain, Avenue Emmanuel Mounier, 73 UCL, Brussels, Belgium

Adrian F. Davis  Limeway Consultancy, Dorking, Surrey, U.K.

Apostolos G. Doukas  Wellman Center for Photomedicine, Massachusetts General Hospital, Boston, Massachusetts, U.S.A.

viii

William E. Dressler  Shelton, Connecticut, U.S.A.

Joseph A. Dunn  Therex LLC, Buffalo, New York, U.S.A.

Anthony C. Dweck  Dweck Data, Salisbury, Wiltshire, U.K.

Richard T. Evans  Therex LLC, Buffalo, New York, U.S.A.

Françoise Falson  Faculté de Pharmacie, Université de Lyon, Lyon, France

Des Fernandes  The Renaissance Body Science Institute, Cape Town, South Africa

Joachim W. Fluhr  Skin Physiology Laboratory, Department of Dermatology, Friedrich Schiller University of Jena, Jena and Bioskin, Berlin, Germany

Claudine Piérard-Franchimont  Department of Dermatopathology, University Hospital of Liège, Liège, Belgium

Carlos Galzote  Johnson & Johnson, Asia Pacific Skin Testing Center, Parañaque City,

Metro Manila, Philippines

Robert J. Genco  Therex LLC, Buffalo, New York, U.S.A.

Raman Govindarajan  Johnson & Johnson Singapore Research Center, Singapore

Jeffrey E. Grice  Therapeutics Research Unit, School of Medicine, University of Queensland, Princess Alexandra Hospital, Woolloongabba, Queensland, Australia

Kate A. Hammer  Department of Microbiology and Immunology, School of Biomedical, Biomolecular, and Chemical Sciences, Faculty of Life and Physical Sciences, The University of Western Australia, Crawley, Western Australia, Australia

Greg G. Hillebrand  Procter & Gamble, Cincinnati, Ohio, U.S.A.

Xiaoying Hui  University of California, San Francisco, San Francisco, California, U.S.A.

Amit Jain  Department of Chemical Engineering, University of California, Santa Barbara, Santa Barbara, California, U.S.A.

Narayanasamy Kanikkannan  Tyco Healthcare Mallinckrodt, Webster Groves, Missouri, U.S.A.

Pankaj Karande  Department of Chemical Engineering, University of California, Santa Barbara, California, U.S.A.

Gerald B. Kasting  James L. Winkle College of Pharmacy, University of Cincinnati Academic Health Center, Cincinnati, Ohio, U.S.A.

Mark A. F. Kendall  Australian Institute for Bioengineering and Nanotechnology (AIBN), The University of Queensland, Brisbane, Queensland, Australia

Neil Kitson  Department of Dermatology and Skin Science, University of British Columbia, Vancouver, British Columbia, Canada

Juergen Lademann  Universitätsklinikum Charité, Klinik für Dermatologie, Venerologie und Allergologie, Berlin, Germany

Chong Jin Loy  Johnson & Johnson Asia Pacific, Singapore Research Center, Singapore Guang Wei Lu  Pfizer Global Research and Development, Ann Arbor, Michigan, U.S.A.

Howard I. Maibach  University of California, San Francisco, San Francisco, California, U.S.A.

Paul John Matts  Procter & Gamble Beauty, Egham, Surrey, U.K.

Contributors

Lars E. Meyer  Universitätsklinikum Charité, Klinik für Dermatologie, Venerologie und Allergologie, Berlin, Germany

Matthew A. Miller  James L. Winkle College of Pharmacy, University of Cincinnati Academic Health Center, Cincinnati, Ohio, U.S.A.

Maria Miteva  Skin Physiology Laboratory, Department of Dermatology, Friedrich Schiller University of Jena, Jena, Germany

Samir Mitragotri  Department of Chemical Engineering, University of California, Santa Barbara, Santa Barbara, California, U.S.A.

Jesper B. Nielsen  Institute of Public Health, University of Southern Denmark, Odense C, Denmark

Johannes M. Nitsche  Department of Chemical Engineering, State University of

New York at Buffalo, Buffalo, New York, U.S.A.

Sumit Paliwal  Department of Chemical Engineering, University of California, Santa Barbara, Santa Barbara, California, U.S.A.

Gérald E. Piérard  Department of Dermatopathology, University Hospital of Liège, Liège, Belgium

Fabrice Pirot  Faculté de Pharmacie, Université de Lyon, Lyon, France

Véronique Préat  Unité de Pharmacie Galénique, Université Catholique de Louvain, Avenue Emmanuel Mounier, 73 UCL, Brussels, Belgium

Pascale Quatresooz  Department of Dermatopathology, University Hospital of Liège, Liège, Belgium

Anthony Vincent Rawlings  AVR Consulting Ltd., Northwich, Cheshire, U.K.

Jürgen Reichling  Department of Biology, Institut of Pharmacy and Molecular Biotechnology, University of Heidelberg, Heidelberg, Germany

Michael S. Roberts  School of Medicine, University of Queensland, Princess Alexandra Hospital, Woolloongabba, Queensland, Australia

Mantu Sarkar  University of Queensland, Princess Alexandra Hospital, Woolloongabba, Queensland, Australia

Ulrich F. Schäfer  Biopharmaceutics and Pharmaceutical Technology, Saarbruecken, Saarland University, Germany

Sonja Schmitt  Department of Biology, Institut of Pharmacy and Molecular Biotechnology, University of Heidelberg, Heidelberg, Germany

Jürgen Schneele  Department of Biology, Institut of Pharmacy and Molecular Biotechnology, University of Heidelberg, Heidelberg, Germany

Jagdish Singh  Department of Pharmaceutical Sciences, College of Pharmacy, North Dakota State University, Fargo, North Dakota, U.S.A.

Michael Suero  Johnson & Johnson, Asia Pacific Skin Testing Center, Parañaque City,

Metro Manila, Philippines

Satyanarayana Valiveti  Pfizer Global Research and Development, Ann Arbor,

Michigan, U.S.A.

Gaëlle Vandermeulen  Unité de Pharmacie Galénique , Université Catholique de Louvain, Avenue Emmanuel Mounier, 73 UCL, Brussels, Belgium

Valérie Vroome  Barrier Therapeutics NV, Geel, Belgium

Kenneth A. Walters  An-eX Analytical Services Ltd., Cardiff, U.K.

Michael W. Whitehouse  University of Queensland, Princess Alexandra Hospital, Woolloongabba, Queensland, Australia

R. Randall Wickett  James L. Winkle College of Pharmacy, University of Cincinnati, Cincinnati, Ohio, U.S.A.

Johann W. Wiechers  JW Solutions, Gouda, Netherlands

Adrian C. Williams  Reading School of Pharmacy, University of Reading, Reading, U.K.